Our results are consistent with those of recent reports showing that the inhibition of the enzymatic activity of IDO significantly exacerbated liver injury in α-galactosylceramide (α-GalCer)- and CCl4-induced acute hepatitis animal models via the upregulation of IL-6 and TNF-α [18,19]. The gene discussed is IDO1; the disease is Acute hepatitis.